NOVATARG THERANOSTICS, INC

Capabilities

NOVATARG Theranostics proposes sole source small business innovation research (SBIR) projects to deploy its pioneering, proprietary and patented Two-Dimensional Long-Range Ordering and Clustering (2D L-ROC) platform, to enable (1) rapid, accurate, label-free COVID-19 antibody and antigen testing, and (2) structure-based, COVID-19 therapeutic and vaccine interventions. NOVATARG’s advances have the potential to accelerate the U.S. readiness to COVID-19 and other future viral threats for which no effective interventions exist.